🇪🇺 Abrocitinib Suspension F1 in European Union

Abrocitinib Suspension F1 (abrocitinib-suspension-f1) regulatory status in European Union.

Marketing authorisation

EMA

  • Status: approved

Abrocitinib Suspension F1 in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Immunology approved in European Union

Frequently asked questions

Is Abrocitinib Suspension F1 approved in European Union?

Yes. EMA has authorised it.

Who is the marketing authorisation holder for Abrocitinib Suspension F1 in European Union?

Pfizer is the originator. The local marketing authorisation holder may differ — check the official source linked above.